Efficacy and safety are comparable for INTERCEPT FFP prepared with photochemical treatment and untreated FFP for therapeutic plasma exchange (TPE) of thrombotic thrombocytopenic purpura (TTP)

Concord, Cerus Corporation United States of America

Vox Sanguinis. 2005;89((S2):):40. Abstract No. 5P-045.
Study details